D. E. Shaw & Co., Inc. Bristol Myers Squibb CO Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 694,700 shares of BMY stock, worth $35.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

694,700

Previous 861,200 19.33%

Holding current value

$35.4 Million

Previous $46.7 Million 38.23%

% of portfolio

0.03%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $69.3 Million - $91.2 Million	1,721,172 Added 234.83%	2,454,102 $102 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $176 Million - $199 Million	-3,663,277 Reduced 83.33%	732,930 $39.7 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $37 Million - $44.2 Million	763,722 Added 21.02%	4,396,207 $226 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $140 Million - $157 Million	2,423,547 Added 200.47%	3,632,485 $211 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $29.1 Million - $32.3 Million	456,476 Added 60.66%	1,208,938 $77.3 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $5.84 Million - $6.62 Million	-88,876 Reduced 10.56%	752,462 $52.2 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $27.4 Million - $32.4 Million	399,485 Added 90.41%	841,338 $60.5 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $38,431 - $22.7 Million	-295,626 Reduced 40.09%	441,853 $31.4 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $37.8 Million - $41.6 Million	-520,735 Reduced 41.39%	737,479 $56.8 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $18.2 Million - $21.9 Million	-296,812 Reduced 19.09%	1,258,214 $91.9 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $65.5 Million - $76.4 Million	1,221,838 Added 366.71%	1,555,026 $97 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $14.2 Million - $16.6 Million	239,367 Added 255.13%	333,188 $19.7 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $10.1 Million - $11 Million	-163,138 Reduced 63.49%	93,821 $6.27 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $2.58 Million - $2.9 Million	-43,431 Reduced 14.46%	256,959 $16.2 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $8.23 Million - $9.33 Million	142,568 Added 90.33%	300,390 $18.6 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $73.4 Million - $81.3 Million	-1,277,316 Reduced 89.0%	157,822 $9.52 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $42.8 Million - $50 Million	780,768 Added 119.32%	1,435,138 $84.4 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $20.7 Million - $30.1 Million	446,410 Added 214.66%	654,370 $36.5 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $39.8 Million - $51.9 Million	-809,258 Reduced 79.56%	207,960 $13.3 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $26.9 Million - $31.9 Million	-628,816 Reduced 38.2%	1,017,218 $51.6 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $92.4 Million - $102 Million	-2,071,050 Reduced 55.72%	1,646,034 $74.6 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $368 Million - $439 Million	-8,166,049 Reduced 68.72%	3,717,084 $177 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $2.52 Million - $3.27 Million	51,707 Added 0.44%	11,883,133 $618 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $66.1 Million - $74.6 Million	-1,197,685 Reduced 9.19%	11,831,426 $734 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $271 Million - $337 Million	5,356,399 Added 69.81%	13,029,111 $721 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $186 Million - $214 Million	3,107,597 Added 68.07%	7,672,712 $485 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $130 Million - $142 Million	2,167,865 Added 90.43%	4,565,115 $280 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $132 Million - $153 Million	2,397,250	2,397,250 $153 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account